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Abstract
In this study, we used red cell glucose-6-phosphate dehydrogenase (G6PD) activity to screen for G6PD-deficient in-
dividuals in 373 unrelated asymptomatic adult men who were working with insecticides (organophosphorus and
carbamate) in dengue prevention programs in 27 cities in São Paulo State, Brazil. Twenty-one unrelated male chil-
dren suspected of having erythroenzymopathy who were attended at hospitals in São Paulo city were also studied.
Fifteen of the 373 adults and 12 of the 21 children were G6PD deficient. G6PD gene mutations were investigated in
these G6PD-deficient individuals by using PCR-RFLP, PCR-SSCP analysis and DNA sequencing. Twelve G6PD
A-202A/376G and two G6PD Seattle844C, as well as a new variant identified as G6PD São Paulo, were detected
among adults, and 11 G6PD A-202A/376G and one G6PD Seattle844C were found among children. The novel mu-
tation c.660C > G caused the replacement of isoleucine by methionine (I220M) in a region near the dimer interface of
the molecule. The conservative nature of this mutation (substitution of a nonpolar aliphatic amino acid for another
one) could explain why there was no corresponding change in the loss of G6PD activity (64.5% of normal activity in
both cases).
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Over 440 glucose-6-phosphate dehydrogenase
(G6PD) variants (Beutler and Vulliamy, 2002) have been
grouped in five classes according to their enzymatic activ-
ity and clinical manifestations (World Health Organiza-
tion-WHO criteria) (Beutler and Yoshida, 1988). The
G6PD gene is highly polymorphic and so far more than 150
mutations resulting in distinct G6PD variants have been de-
scribed (Beutler and Vulliamy, 2002; Hamel et al., 2002;
Rodrigues et al., 2002; Vaca et al., 2003; Drousiotou et al.,
2004; Grabowska et al., 2004; van Wijk et al., 2004; Yan et
al., 2006; Maciag et al., 2007; Mason et al., 2007; Matsuo-
ka et al., 2007; McDade et al., 2008; Minucci et al., 2008;
Nuchprayoon et al., 2008). Most of these mutations show
low enzyme activity and only five are class IV variants:
G6PD São Borja337G > A (Weimer et al., 1993), G6PD
A376A > G (Takizawa et al., 1987), G6PD San Luis
Potosi376A > T (Vaca et al., 2003), G6PD Insuli989G > A
(Sukumar et al., 2003), and G6PD Mira d’Aire1048G > C
(Beutler and Vulliamy, 2002).
In this study, we screened for G6PD gene mutations
in a series of G6PD-deficient adult males who were work-
ing with insecticides (organophosphorus and carbamate) in
dengue prevention and in a group of unrelated male chil-
dren suspected of having erythroenzymopathy.
Subjects: Blood samples from 373 unrelated asymp-
tomatic adult males who had been exposed to toxic chemi-
cals in different regions (27 cities) of São Paulo State,
Brazil, and from 21 unrelated male children suspected of
having erythroenzymopathy who were treated at hospitals
Genetics and Molecular Biology, 32, 2, 251-254 (2009)
Copyright © 2009, Sociedade Brasileira de Genética. Printed in Brazil
www.sbg.org.br
Send correspondence to Mario H Hirata. Faculdade de Ciências
Farmacêuticas, Universidade de São Paulo, Avenida Lineu Prestes
580, bloco B17, Cidade Universitária Armando de Salles Oliveira,
Butantan, 05508-900 São Paulo, SP, Brazil. E-mail:
mhhirata@usp.br.
Short Communication
in São Paulo city were screened for G6PD activity. This
study was aproved by the Ethical Commitee of the Faculty
of Pharmaceutical Sciences (protocol no. 214/2003) of the
University of São Paulo, and formal consent was obtained
from all participants prior to enrollment in the study.
Biochemical analysis: Red cell G6PD activity was as-
sayed according to Beutler (1990). Individuals with G6PD
activity lower than 70% of normal values were screened for
G6PD gene mutations by PCR-RFLP (restriction fragment
length polymorphism) or PCR-SSCP (single strand confor-
mation polymorphism).
Fifteen of the 373 blood samples (4%) from adult
males were G6PD deficient and screened for mutations.
One sample with 64.5% of normal G6PD activity
(7.8 IU.gHb-1.min-1 at 37 °C) compared to control levels
(12.1 IU.gHb-1.min-1 at 37 °C) was also included in the mu-
tation study since this value was considered to be border-
line for normal activity (according to WHO criteria, normal
activity is > 60% of control levels). Twelve of the 21 chil-
dren were G6PD deficient and were also screened for muta-
tions.
DNA analysis: Genomic DNA was extracted from
leukocytes (Salazar et al., 1998) and RFLP analysis for
G6PD A+376G, G6PD A-202A/376G and G6PD Mediter-
ranean 563C polymorphic mutations was done using a pro-
cedure modified from Saad et al. (1997). The polymerase
chain reaction (PCR) for RFLP or SSCP was done in a total
volume of 50 L using 100 ng of genomic DNA, 15 pmol of
each oligonucleotide, 0.2 mM of each dNTP, 1 U of DNA
polymerase (Biotools), and 1x reaction buffer (10x PCR
buffer; Biotools). The primers used were previously de-
scribed by Beutler et al. (1989) and Poggi et al. (1990). For
RFLP analysis, the PCR products of exons 4, 5 and 6 were
digested with NlaIII, FokI and MboII restriction endo-
nucleases, respectively. Negative samples for A+376G,
A-202A/376G and Mediterranean563C mutations were an-
alyzed by SSCP, according to Beutler et al. (1989) and
Poggi et al. (1990). The PCR products were denatured in
95% formamide, 0.005% bromophenol blue, 20 mM
EDTA and 0.005% xylenecyanol in 10 mM Tris-HCl, pH
8.0, at 95 °C for 8 min followed by rapid cooling on ice.
Polyacrylamide gel electrophoresis was done at 600 V, 25
mA and 15 W using GeneGel Excel 12.5/24 in the
GenePhor System (Pharmacia Biosciences, Uppsala, Swe-
den for 90 min at two temperatures (5 °C and 15 °C). The
gels were stained with silver nitrate (Sambrook et al.,
1989). The resulting bands were compared with a normal
control and fragments with any alteration were purified
(QIAquick PCR purification Kit, Qiagen Inc., Chastworth,
CA, USA) and directly sequenced with sense and antisense
primers in a model 3100 capillary automatic sequencer
(Applied Biosystem, Foster City, CA, USA). For haplotype
determination, six intragenic polymorphic sites were ana-
lyzed, as described by Rodrigues et al. (2002): exon 5,
376A > G, FokI; intron 5, 611C > G, PvuII; intron 8,
163C > T, BspHI; exon 10, 116G > A, PstI; exon 11, 1311
C > T, Bcl I and intron 11, 93T > C, NlaIII. Restriction en-
zyme digestions were done according to the manufacturer’s
instructions (New England Biolabs, Ipswich, MA, USA).
The polymorphic haplotypes were recorded as (+) or (-) if
the restriction site was present or absent, respectively.
PCR-RFLP analysis showed that 12 of the 15 adult
males had G6PD A-202A/376G mutation (202G > A and
376G > A mutations). All but one of the G6PD-deficient
children (11/12) also had this mutation. All of the mutations
had the haplotype VIa (+ + - + - +).
Two G6PD-deficient adults and the child without the
G6PD A-202A/376G mutation had a different SSCP pat-
tern for exon 8 compared to the controls. This exon was
subsequently sequenced and the variant identified as G6PD
Seattle (844G > C). These variants had the haplotype I (- - +
+ - -).
The sample with 64.5% G6PD activity showed no
mutations in RFLP analysis, but SSCP analysis revealed a
different profile in exon 7 compared to the normal control
(Figure 1). DNA sequencing of the PCR product of exon 7
revealed a novel point mutation, c.660C > G (Figure 2), that
led to the replacement of isoleucin by methionine (I220M).
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Figure 1 - SSCP patterns of G6PD exon 7. Electrophoresis was done at 5 °C (A), 8 °C (B), 12 °C (C) and 15 °C (D). Lane 1: G6PD B control. Lane 2:
G6PD São Paulo variant.
This mutation was associated with haplotype I (- - + + - -)
and the new variant was designated as G6PD São Paulo.
Polymorphic variants: Most of the individuals in-
cluded in the DNA analysis had a G6PD A- 202G > A mu-
tation that is frequently found in African descendents from
Central Africa, thus confirming the results obtained by
Saad et al. (1997). In their study of 150 G6PD-deficient
blood donors, these authors observed the A- 202G > A mu-
tation in 146 individuals (97.3%), indicating that this vari-
ant is the most frequent G6PD deficiency in the population
of southeastern Brazil. G6PD Mediterranean but did not de-
tect any G6PD Seattle. In contrast, in a sample from the
same population, we found G6PD Seattle but not G6PD
Mediterranean. This variation may reflect the ethnic heter-
ogeneity of the population in the state of São Paulo.
Haplotype analysis: All individuals with G6PD A-
202G > A had the characteristic haplotype VIa (+ + - + - +),
which is very common in Brazilian (Saad et al., 1997) and
Portuguese (Rodrigues et al., 2002) populations. Seattle
variant carriers had the haplotype I (- - + + - -) that was also
present in the G6PD São Paulo variant described here.
G6PD São Paulo variant: The large number of G6PD
mutations that cause low enzymatic activity (classes I, II
and III) indicates that the tertiary structure of the protein
probably has many more critical sites that affect the en-
zymes stability and activity than non-critical sites.
However, this conclusion may reflect the fact that most mo-
lecular studies of G6PD have been done only in patients
with hemolytic crises. Class IV variants have rarely been
detected because carriers have near normal G6PD activity,
and only five of them have been studied molecularly (Wei-
mer et al., 1993; Takizawa et al., 1987; Beutler and Vul-
liamy, 2002; Vaca et al., 2003; Sukumar et al., 2003). As
shown here we have identified a novel class IV G6PD vari-
ant in a male with borderline G6PD activity. A novel muta-
tion c.660 (C > G) was detected in exon 7, surprisingly
close to the dimer interface. According to Naylor et al.
(1996) and Au et al. (2000), exon 10, the first half of exon
11, and the second half of exon 6 up to the first half of exon
7 are involved in the dimer interface and are crucial for
G6PD stability and activity.
All of the mutations described so far in this region
(Harilaou 648T > G, class I; Radlowo 679C > T, class I;
“Mexico City” 680G > A, class III; A- 680G > T, class III)
significantly reduce G6PD activity (Hirono and Beutler,
1988; Poggi et al., 1990; Beutler et al., 1992; Jablonska-
Skwiecinska et al., 1999). In the Harilaou, Radlowo and
“Mexico City” A- mutations, the changes occurred between
residues with distinct characteristics: 216Phe (nonpolar ar-
omatic) > Leu (nonpolar aliphatic), 227Arg (polar alkaline)
> Trp (apolar aromatic), 227Arg (polar alkaline) > Gln (po-
lar neutral), and Arg (polar alkaline) > Leu (apolar ali-
phatic), respectively (Hirono and Beutler, 1988; Poggi et
al., 1990; Beutler et al., 1992; Jablonska-Skwiecinska et
al., 1999). It is possible that the substitution of a nonpolar
aliphatic amino acid for another amino acid with similar
properties (I220L) was crucial for maintaining fairly nor-
mal catalytic activity in the novel G6PD variant identified
here.
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